Kiniksa Pharmaceuticals
+$0.37 (+2.61%) Today
-$0.02 (-0.14%) As of 8:00 PM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KNSA and other ETFs, options, and stocks.
About KNSA
Kiniksa Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Its products include Rilonacept, Mavrilimumab, Vixarelimab, and KPL-404.
CEO
Sanj K. Patel
Employees
168
Headquarters
Hamilton, Hamilton
Founded
2015
KNSA Key Statistics
Market Cap
995.69M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
328.01K
High Today
$14.62
Low Today
$14.09
Open Price
$14.23
Volume
659.72K
52 Week High
$24.70
52 Week Low
$13.00
KNSA Earnings
-$0.80
-$0.53
-$0.27
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Aug 3, Pre-Market